Institutional Repository of Vilnius University
Bakterijų priešvirusinės CRISPR-Cas sistemos slopiklių tyrimas /
Abstract
dc:descriptionConstant interactions between bacteria and bacteriophages drive the development of various defense mechanisms of bacteria protecting them against bacteriophage infections. The CRISPR-Cas (clustered regularly interspaced short palindromic repeats - CRISPR associated) is an adaptive defense system, which inserts genetic information about the invader into the CRISPR region and subsequently uses it to recognize and destroy the nucleic acid of the intruder. However, bacteriophages are able to evade this protection by synthesizing small anti-CRISPR (Acr) proteins that block the action of CRISPR-Cas effectors. AcrIF proteins inhibit the activity of type I-F CRISPR-Cas systems. These proteins usually block the ribonucleoprotein Cascade (CRISPR-associated complex for antiviral defense) complex, preventing it from recognizing bacteriophage DNA, or the Cas2/3 helicase-nuclease, which can no longer cut bacteriophage DNA. Currently, 24 families of AcrIF proteins have been identified, but the mechanisms of action have not been studied for all families. This work aimed to identify the AcrIF proteins inhibiting the type I-F CRISPR-Cas system of Pseudomonas aeruginosa bacteria. Active inhibitors were selected by cell viability assay. The detailed mechanism of action was investigated for the AcrIF18 protein. AcrIF18 has been shown to bind to the Cas8f and/or Cas5f proteins of the Cascade complex, thereby interfering with the interaction of the complex with its DNA target.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Graužinytė, Melita,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD192844055&prefLang=en_US